{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:30:44Z","timestamp":1788496244178,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suzhou Science and Technology Bureau Project","award":["SKY2023146"],"award-info":[{"award-number":["SKY2023146"]}]},{"name":"Suzhou Science and Technology Bureau Project","award":["SSD2024083"],"award-info":[{"award-number":["SSD2024083"]}]},{"DOI":"10.13039\/501100010246","name":"Postdoctoral Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["2024M752334"],"award-info":[{"award-number":["2024M752334"]}],"id":[{"id":"10.13039\/501100010246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202242"],"award-info":[{"award-number":["JSDW202242"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To develop and validate radiomics and deep learning models based on contrast-enhanced MRI (CE-MRI) for differentiating dual-phenotype hepatocellular carcinoma (DPHCC) from HCC and intrahepatic cholangiocarcinoma (ICC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Our study consisted of 381 patients from four centers with 138 HCCs, 122 DPHCCs, and 121 ICCs (244 for training and 62 for internal tests, centers 1 and 2; 75 for external tests, centers 3 and 4). Radiomics, deep transfer learning (DTL), and fusion models based on CE-MRI were established for differential diagnosis, respectively, and their diagnostic performances were compared using the confusion matrix and area under the receiver operating characteristic (ROC) curve (AUC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The radiomics model demonstrated competent diagnostic performance, with a macro-AUC exceeding 0.9, and both accuracy and F1-score above 0.75 in the internal and external validation sets. Notably, the vgg19-combined model outperformed the radiomics and other DTL models. The fusion model based on vgg19 further improved diagnostic performance, achieving a macro-AUC of 0.990 (95% CI: 0.965\u20131.000), an accuracy of 0.935, and an F1-score of 0.937 in the internal test set. In the external test set, it similarly performed well, with a macro-AUC of 0.988 (95% CI: 0.964\u20131.000), accuracy of 0.875, and an F1-score of 0.885.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Both the radiomics and the DTL models were able to differentiate DPHCC from HCC and ICC before surgery. The fusion models showed better diagnostic accuracy, which has important value in clinical application.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Critical relevance statement<\/jats:title>\n            <jats:p>MRI-based deep learning radiomics were able to differentiate DPHCC from HCC and ICC preoperatively, aiding clinicians in the identification and targeted treatment of these malignant hepatic tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Fusion models may yield an incremental value over radiomics models in differential diagnosis.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Radiomics and deep learning effectively differentiate the three types of malignant hepatic tumors.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>The fusion models may enhance clinical decision-making for malignant hepatic tumors.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13244-025-01904-y","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:13:50Z","timestamp":1738174430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["MRI-based deep learning radiomics to differentiate dual-phenotype hepatocellular carcinoma from HCC and intrahepatic cholangiocarcinoma: a multicenter study"],"prefix":"10.1186","volume":"16","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6343-758X","authenticated-orcid":false,"given":"Chunhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"1904_CR1","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM et al (2017) Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med 23:1424\u20131435","journal-title":"Nat Med"},{"key":"1904_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","volume":"74","author":"A Beaufr\u00e8re","year":"2021","unstructured":"Beaufr\u00e8re A, Calderaro J, Paradis V (2021) Combined hepatocellular-cholangiocarcinoma: an update. J Hepatol 74:1212\u20131224","journal-title":"J Hepatol"},{"key":"1904_CR3","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1245\/s10434-011-1585-7","volume":"18","author":"X-Y Lu","year":"2011","unstructured":"Lu X-Y, Xi T, Lau W-Y et al (2011) Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior. Ann Surg Oncol 18:2210\u20132217","journal-title":"Ann Surg Oncol"},{"key":"1904_CR4","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.7150\/jca.41090","volume":"11","author":"J Zhang","year":"2020","unstructured":"Zhang J, Qi YP, Ma N et al (2020) Overexpression of Epcam and CD133 correlates with poor prognosis in dual-phenotype hepatocellular carcinoma. J Cancer 11:3400\u20133406","journal-title":"J Cancer"},{"key":"1904_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41419-021-04320-4","volume":"12","author":"J Zhuo","year":"2021","unstructured":"Zhuo J, Lu D, Lin Z et al (2021) The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib. Cell Death Dis 12:1084","journal-title":"Cell Death Dis"},{"key":"1904_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/gutjnl-2012-304351","volume":"63","author":"O Govaere","year":"2014","unstructured":"Govaere O, Komuta M, Berkers J et al (2014) Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut 63:674\u2013685","journal-title":"Gut"},{"key":"1904_CR7","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1158\/1078-0432.CCR-14-1936","volume":"21","author":"T Kawai","year":"2015","unstructured":"Kawai T, Yasuchika K, Ishii T et al (2015) Keratin 19, a cancer stem cell marker in human hepatocellular carcinoma. Clin Cancer Res 21:3081\u20133091","journal-title":"Clin Cancer Res"},{"key":"1904_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1253873","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Chen J, Lai X, Zhang X, Xu J (2023) Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis. Front Oncol 13:1253873","journal-title":"Front Oncol"},{"key":"1904_CR9","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1007\/s10278-023-00888-9","volume":"36","author":"HX Gu","year":"2023","unstructured":"Gu HX, Huang XS, Xu JX, Zhu P, Xu JF, Fan SF (2023) Diagnostic value of MRI features in dual-phenotype hepatocellular carcinoma: a preliminary study. J Digit Imaging 36:2554\u20132566","journal-title":"J Digit Imaging"},{"key":"1904_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000328448","volume":"80","author":"K Tsuchiya","year":"2011","unstructured":"Tsuchiya K, Komuta M, Yasui Y et al (2011) Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation. Oncology 80:278\u2013288","journal-title":"Oncology"},{"key":"1904_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/JHC.S395903","volume":"10","author":"C Lin","year":"2023","unstructured":"Lin C, He Y, Liu M et al (2023) Vessels that encapsulate tumor clusters (VETC) predict cTACE response in hepatocellular carcinoma. J Hepatocell Carcinoma 10:383\u2013397","journal-title":"J Hepatocell Carcinoma"},{"key":"1904_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s11547-023-01715-5","volume":"128","author":"MT Liu","year":"2023","unstructured":"Liu MT, Zhang JY, Xu L et al (2023) A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual\u2011phenotype hepatocellular carcinoma. Radio Med 128:1333\u20131346","journal-title":"Radio Med"},{"key":"1904_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749\u2013762","journal-title":"Nat Rev Clin Oncol"},{"key":"1904_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G et al (2020) Introduction to radiomics. J Nucl Med 61:488\u2013495","journal-title":"J Nucl Med"},{"key":"1904_CR15","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.7150\/thno.37429","volume":"10","author":"J Fang","year":"2020","unstructured":"Fang J, Zhang B, Wang S et al (2020) Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer. Theranostics 10:2284\u20132292","journal-title":"Theranostics"},{"key":"1904_CR16","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1158\/1078-0432.CCR-18-4067","volume":"26","author":"RD Chitalia","year":"2020","unstructured":"Chitalia RD, Rowland J, McDonald ES et al (2020) Imaging phenotypes of breast cancer heterogeneity in preoperative breast dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) scans predict 10-year recurrence. Clin Cancer Res 26:862\u2013869","journal-title":"Clin Cancer Res"},{"key":"1904_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11007-0","volume":"10","author":"N Elshafeey","year":"2019","unstructured":"Elshafeey N, Kotrotsou A, Hassan A et al (2019) Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun 10:3170","journal-title":"Nat Commun"},{"key":"1904_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47992-y","volume":"13","author":"OS Khedr","year":"2023","unstructured":"Khedr OS, Wahed ME, Al-Attar AR, Abdel-Rehim EA (2023) The classification of the bladder cancer based on vision transformers (ViT). Sci Rep 13:20639","journal-title":"Sci Rep"},{"key":"1904_CR19","doi-asserted-by":"crossref","unstructured":"Asiri AA, Shaf A, Ali T et al (2023) Exploring the power of deep learning: fine-tuned vision transformer for accurate and efficient brain tumor detection in MRI scans. Diagnostics (Basel) 13:2094","DOI":"10.3390\/diagnostics13122094"},{"key":"1904_CR20","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1158\/1078-0432.CCR-18-1115","volume":"24","author":"SS Aboutalib","year":"2018","unstructured":"Aboutalib SS, Mohamed AA, Berg WA, Zuley ML, Sumkin JH, Wu S (2018) Deep learning to distinguish recalled but benign mammography images in breast cancer screening. Clin Cancer Res 24:5902\u20135909","journal-title":"Clin Cancer Res"},{"key":"1904_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02726-3","volume":"9","author":"LG Pang","year":"2018","unstructured":"Pang LG, Zhou K, Su N, Petersen H, St\u00f6cker H, Wang XN (2018) An equation-of-state-meter of quantum chromodynamics transition from deep learning. Nat Commun 9:210","journal-title":"Nat Commun"},{"key":"1904_CR22","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1158\/1078-0432.CCR-18-0385","volume":"24","author":"C Parmar","year":"2018","unstructured":"Parmar C, Barry JD, Hosny A, Quackenbush J, Aerts H (2018) Data analysis strategies in medical imaging. Clin Cancer Res 24:3492\u20133499","journal-title":"Clin Cancer Res"},{"key":"1904_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts H (2018) Artificial intelligence in radiology. Nat Rev Cancer 18:500\u2013510","journal-title":"Nat Rev Cancer"},{"key":"1904_CR24","doi-asserted-by":"publisher","first-page":"eaaw1949","DOI":"10.1126\/sciadv.aaw1949","volume":"5","author":"JA Aguiar","year":"2019","unstructured":"Aguiar JA, Gong ML, Unocic RR, Tasdizen T, Miller BD (2019) Decoding crystallography from high-resolution electron imaging and diffraction datasets with deep learning. Sci Adv 5:eaaw1949","journal-title":"Sci Adv"},{"key":"1904_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19303-w","volume":"11","author":"PD L\u00f6sel","year":"2020","unstructured":"L\u00f6sel PD, van de Kamp T, Jayme A et al (2020) Introducing Biomedisa as an open-source online platform for biomedical image segmentation. Nat Commun 11:5577","journal-title":"Nat Commun"},{"key":"1904_CR26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222223","volume":"307","author":"X Jiang","year":"2023","unstructured":"Jiang X, Zhao H, Saldanha OL et al (2023) An MRI deep learning model predicts outcome in rectal cancer. Radiology 307:e222223","journal-title":"Radiology"},{"key":"1904_CR27","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1007\/s00330-020-07559-1","volume":"31","author":"PM Oestmann","year":"2021","unstructured":"Oestmann PM, Wang CJ, Savic LJ et al (2021) Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver. Eur Radiol 31:4981\u20134990","journal-title":"Eur Radiol"},{"key":"1904_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-023-01023-4","volume":"23","author":"M Meng","year":"2023","unstructured":"Meng M, Li H, Zhang M, He G, Wang L, Shen D (2023) Reducing the number of unnecessary biopsies for mammographic BI-RADS 4 lesions through a deep transfer learning method. BMC Med Imaging 23:82","journal-title":"BMC Med Imaging"},{"key":"1904_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.986437","volume":"9","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Li H, Zhu Y et al (2022) Development and validation of a predictive model combining clinical, radiomics, and deep transfer learning features for lymph node metastasis in early gastric cancer. Front Med 9:986437","journal-title":"Front Med"},{"key":"1904_CR30","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1007\/s00330-021-07858-1","volume":"31","author":"S Nowak","year":"2021","unstructured":"Nowak S, Mesropyan N, Faron A et al (2021) Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning. Eur Radiol 31:8807\u20138815","journal-title":"Eur Radiol"},{"key":"1904_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41575-020-0314-8","volume":"17","author":"H Petrowsky","year":"2020","unstructured":"Petrowsky H, Fritsch R, Guckenberger M, De Oliveira ML, Dutkowski P, Clavien PA (2020) Modern therapeutic approaches for the treatment of malignant liver tumours. Nat Rev Gastroenterol Hepatol 17:755\u2013772","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1904_CR32","doi-asserted-by":"crossref","unstructured":"Torres CM, Biran A, Burney MJ et al (2016) The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity. Science 353:aaf1644","DOI":"10.1126\/science.aaf1644"},{"key":"1904_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41568-018-0095-3","volume":"19","author":"U Ben-David","year":"2019","unstructured":"Ben-David U, Beroukhim R, Golub TR (2019) Genomic evolution of cancer models: perils and opportunities. Nat Rev Cancer 19:97\u2013109","journal-title":"Nat Rev Cancer"},{"key":"1904_CR34","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1093\/nar\/gkz717","volume":"47","author":"R Viswanathan","year":"2019","unstructured":"Viswanathan R, Cheruba E, Cheow LF (2019) DNA analysis by restriction enzyme (DARE) enables concurrent genomic and epigenomic characterization of single cells. Nucleic Acids Res 47:e122","journal-title":"Nucleic Acids Res"},{"key":"1904_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00268-016-3787-4","volume":"41","author":"DH Jung","year":"2017","unstructured":"Jung DH, Hwang S, Kim KH et al (2017) Clinicopathological features and post-resection prognosis of double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma. World J Surg 41:825\u2013834","journal-title":"World J Surg"},{"key":"1904_CR36","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.7150\/jca.56005","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang X, Huang X et al (2021) Integrated genomic and transcriptomic analysis reveals key genes for predicting dual-phenotype hepatocellular carcinoma prognosis. J Cancer 12:2993\u20133010","journal-title":"J Cancer"},{"key":"1904_CR37","doi-asserted-by":"publisher","unstructured":"Wu Q, Yu YX, Zhang T et al (2022) Preoperative diagnosis of dual-phenotype hepatocellular carcinoma using enhanced MRI radiomics models. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.28391","DOI":"10.1002\/jmri.28391"},{"key":"1904_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1055\/s-0042-124347","volume":"189","author":"S Huf","year":"2017","unstructured":"Huf S, Platz Batista da Silva N, Wiesinger I et al (2017) Analysis of liver tumors using preoperative and intraoperative contrast-enhanced ultrasound (CEUS\/IOCEUS) by radiologists in comparison to magnetic resonance imaging and histopathology. Rofo 189:431\u2013440","journal-title":"Rofo"},{"key":"1904_CR39","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.ultrasmedbio.2023.03.026","volume":"49","author":"Y Dong","year":"2023","unstructured":"Dong Y, Chen S, M\u00f6ller K et al (2023) Applications of dynamic contrast-enhanced ultrasound in differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in non-cirrhotic liver. Ultrasound Med Biol 49:1780\u20131788","journal-title":"Ultrasound Med Biol"},{"key":"1904_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2020.03.022","volume":"181","author":"J Goecks","year":"2020","unstructured":"Goecks J, Jalili V, Heiser LM, Gray JW (2020) How machine learning will transform biomedicine. Cell 181:92\u2013101","journal-title":"Cell"},{"key":"1904_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17419-7","volume":"11","author":"JG Richens","year":"2020","unstructured":"Richens JG, Lee CM, Johri S (2020) Improving the accuracy of medical diagnosis with causal machine learning. Nat Commun 11:3923","journal-title":"Nat Commun"},{"key":"1904_CR42","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00330-021-08250-9","volume":"32","author":"Y Yu","year":"2022","unstructured":"Yu Y, Fan Y, Wang X et al (2022) Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma. Eur Radiol 32:959\u2013970","journal-title":"Eur Radiol"},{"key":"1904_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1148\/radiol.220329","volume":"306","author":"Y Bian","year":"2023","unstructured":"Bian Y, Zheng Z, Fang X et al (2023) Artificial intelligence to predict lymph node metastasis at CT in pancreatic ductal adenocarcinoma. Radiology 306:160\u2013169","journal-title":"Radiology"},{"key":"1904_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13045-021-01167-2","volume":"14","author":"R Gao","year":"2021","unstructured":"Gao R, Zhao S, Aishanjiang K et al (2021) Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data. J Hematol Oncol 14:154","journal-title":"J Hematol Oncol"},{"key":"1904_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110560","volume":"157","author":"Q Xu","year":"2022","unstructured":"Xu Q, Xu QQ, Shi N, Dong LN, Zhu H, Xu K (2022) A multitask classification framework based on vision transformer for predicting molecular expressions of glioma. Eur J Radiol 157:110560","journal-title":"Eur J Radiol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-01904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-01904-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-01904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:14:00Z","timestamp":1738174440000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-01904-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-01904-y","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the local Institutional Review Board of the participating institutes (ethics approval number: 2021331), and the informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}